BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32116238)

  • 1. Thrombotic risk in paroxysmal nocturnal hemoglobinuria-like (PNH-like) phenotype.
    Carlisi M; Mancuso S; Caimi G; Siragusa S
    Clin Hemorheol Microcirc; 2021; 79(4):491-503. PubMed ID: 32116238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum.
    Wilcox LA; Ezzell JL; Bernshaw NJ; Parker CJ
    Blood; 1991 Aug; 78(3):820-9. PubMed ID: 1713516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PNH--paroxysmal nocturnal hemoglobinuria. An old disease explained by new technology].
    Hast R
    Lakartidningen; 1997 Nov; 94(47):4323-6. PubMed ID: 9424527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxysmal nocturnal hemoglobinuria.
    Čermák J
    Vnitr Lek; 2018; 64(5):508-513. PubMed ID: 30193519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complement alternative pathway in paroxysmal nocturnal hemoglobinuria: From a pathogenic mechanism to a therapeutic target.
    Risitano AM; Frieri C; Urciuoli E; Marano L
    Immunol Rev; 2023 Jan; 313(1):262-278. PubMed ID: 36110036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria.
    Lin LI; Chen YC; Lin JK
    Hematology; 1997; 2(5):399-406. PubMed ID: 27405407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria.
    Holguin MH; Wilcox LA; Bernshaw NJ; Rosse WF; Parker CJ
    J Clin Invest; 1989 Nov; 84(5):1387-94. PubMed ID: 2478585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Rare Case of Paroxysmal Nocturnal Hemoglobinuria With Bilateral Renal Vein Thrombosis.
    Lodhi OUH; Sohail S; Hassan D
    Cureus; 2020 Jun; 12(6):e8806. PubMed ID: 32724752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies.
    Risitano AM
    Adv Exp Med Biol; 2013; 735():155-72. PubMed ID: 23402025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paroxysmal nocturnal hemoglobinuria and thrombosis in the era of eculizumab].
    Nishimura JI
    Rinsho Ketsueki; 2018; 59(8):1042-1047. PubMed ID: 30185704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis.
    Rosse WF; Hoffman S; Campbell M; Borowitz M; Moore JO; Parker CJ
    Br J Haematol; 1991 Sep; 79(1):99-107. PubMed ID: 1716964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Paroxysmal nocturnal hemoglobinuria (PNH) deficiency of major complement-regulatory membrane proteins on erythrocytes].
    Ninomiya H; Kobayashi T; Abe T
    Rinsho Ketsueki; 1991 Jun; 32(6):612-7. PubMed ID: 1716325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory diagnosis of paroxysmal nocturnal hemoglobinuria.
    Krauss JS
    Ann Clin Lab Sci; 2003; 33(4):401-6. PubMed ID: 14584753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxysmal nocturnal hemoglobinuria: An acquired genetic disease.
    Nishimura J; Murakami Y; Kinoshita T
    Am J Hematol; 1999 Nov; 62(3):175-82. PubMed ID: 10539884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Noji H
    Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosyl phosphatidylinositol-linked blood group antigens and paroxysmal nocturnal hemoglobinuria.
    Telen MJ
    Transfus Clin Biol; 1995; 2(4):277-90. PubMed ID: 8542026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxysmal nocturnal haemoglobinuria.
    Hill A; DeZern AE; Kinoshita T; Brodsky RA
    Nat Rev Dis Primers; 2017 May; 3():17028. PubMed ID: 28516949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor.
    Holguin MH; Martin CB; Bernshaw NJ; Parker CJ
    J Immunol; 1992 Jan; 148(2):498-502. PubMed ID: 1370313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.
    Nicholson-Weller A; March JP; Rosenfeld SI; Austen KF
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5066-70. PubMed ID: 6576376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins in clinical pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH).
    Shichishima T
    Fukushima J Med Sci; 1995 Jun; 41(1):1-13. PubMed ID: 8606038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.